Pharmacology of the short QT syndrome N588K-hERG K+ channel mutation: differential impact on selected class I and class III antiarrhythmic drugs.

Source:http://linkedlifedata.com/resource/pubmed/id/18724381

Download in:

View as

General Info

PMID
18724381